BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$151M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$126M |
| 3 |
Alibaba
BABA
|
+$92.6M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$71M |
| 5 |
Lam Research
LRCX
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.15B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Apple
AAPL
|
+$837M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$723M |
| 5 |
Microsoft
MSFT
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.13% |
| 2 | Financials | 5.89% |
| 3 | Healthcare | 5.09% |
| 4 | Consumer Discretionary | 5% |
| 5 | Communication Services | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
TriMas Corp
TRS
$1.4B
| $92.2K | ﹤0.01% |
3,380
+716
| +27% | +$20.4K |
|
|
TBI
2327
Trueblue
TBI
$311M
| $92.1K | ﹤0.01% |
4,140
-436
| -10% | -$10.5K |
|
2328
Trustmark
TRMK
$2.8B
| $92K | ﹤0.01% |
3,237
-4,692
| -59% | -$145K |
|
2329
Rogers Corp
ROG
$2.55B
| $91.2K | ﹤0.01% |
921
-143
| -13% | -$17.2K |
|
2330
Merit Medical Systems
MMSI
$5.42B
| $91.1K | ﹤0.01% |
1,632
-1,179
| -42% | -$70.1K |
|
|
HMSY
2331
DELISTED
HMS Holdings Corp.
HMSY
| $91.1K | ﹤0.01% |
3,237
-1,544
| -32% | -$50K |
|
2332
Itron
ITRI
$4.45B
| $91K | ﹤0.01% |
1,924
-683
| -26% | -$36.1K |
|
2333
MACOM Technology Solutions
MTSI
$24.2B
| $90.8K | ﹤0.01% |
6,260
-15,784
| -72% | -$255K |
|
2334
Nelnet
NNI
$4.57B
| $89.9K | ﹤0.01% |
1,718
+707
| +70% | +$38.1K |
|
2335
Andersons Inc
ANDE
$2.24B
| $89.9K | ﹤0.01% |
3,007
+792
| +36% | +$26.5K |
|
|
GNC
2336
PUT
DELISTED
GNC Holdings, Inc.
GNC
| $88.9K | ﹤0.01% |
375
-120
| -24% | -$403 |
|
2337
Haemonetics
HAE
$4.13B
| $87.7K | ﹤0.01% |
877
-5,361
| -86% | -$563K |
|
2338
CALL
Nabors Industries
NBR
$1.39B
| $87.6K | ﹤0.01% |
9
-1
| -10% | -$220 |
|
2339
ITT
ITT
$19.6B
| $87.4K | ﹤0.01% |
1,811
-7,862
| -81% | -$415K |
|
|
CONE
2340
DELISTED
CyrusOne Inc Common Stock
CONE
| $87.4K | ﹤0.01% |
1,653
-31,386
| -95% | -$1.79M |
|
2341
Applied Industrial Technologies
AIT
$13.4B
| $87.2K | ﹤0.01% |
1,616
-605
| -27% | -$39.5K |
|
2342
Hubbell
HUBB
$27B
| $87.1K | ﹤0.01% |
877
-9,987
| -92% | -$1.1M |
|
2343
Trade Desk
TTD
$6.64B
| $87K | ﹤0.01% |
7,500
-10,510
| -58% | -$132K |
|
|
SYKE
2344
DELISTED
SYKES Enterprises Inc
SYKE
| $87K | ﹤0.01% |
3,518
+1,157
| +49% | +$32.3K |
|
|
VXX
2345
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $86.7K | ﹤0.01% |
1,849
-422,400
| -100% | -$15.6M |
|
2346
Emergent Biosolutions
EBS
$235M
| $86.6K | ﹤0.01% |
1,461
-5,122
| -78% | -$330K |
|
2347
PUT
3D Systems Corp
DDD
$616M
| $86.4K | ﹤0.01% |
85
-45
| -35% | -$617 |
|
2348
Renasant Corp
RNST
$3.98B
| $86.1K | ﹤0.01% |
2,853
-1,480
| -34% | -$51.9K |
|
|
NEWR
2349
DELISTED
New Relic, Inc.
NEWR
| $86.1K | ﹤0.01% |
1,063
-73,924
| -99% | -$6.23M |
|
2350
Cinemark Holdings
CNK
$4.33B
| $86K | ﹤0.01% |
2,401
-9,710
| -80% | -$384K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2018 Portfolio in Review
As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.
- BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
- BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
- BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
- BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
- BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
- BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.